Back to search

Aristotle University Of Thessaloniki (AUTH)

Ανοσοϊστοχημική μελέτη έκφρασης πρωτεϊνών που σχετίζονται με την υποξία των όγκων στον καρκίνο του προστάτη: συσχέτιση με κλινικοεργαστηριακούς δείκτες

Abstract

dc:description

Prostate cancer is the most common cancer in men and in fact in the black race, where it is endemic, it is the most common cancer in humans. One in 6 men will develop prostate cancer in their lifetime, with a new diagnosis every 15 minutes. The probability of occurrence increases with age starting from 40 years. In most cases it has a long course of progress with treatment, while the frequency of death shows a gradual decrease. This is due to a) its early detection with the widespread spread of PSA, b) its generally slow progression in older age, which is more common, and c) due to the newer drug therapies used in the last 4 years. About half of localized prostate cancers will be cured in the localized stage of the disease. The other half will develop, usually with the appearance of metastases. The main mediator of biological actions, which occur in various states of tissue hypoxia in order to compensate for it and maintain the survival and function of cells, both normal and cancerous, is the hypoxia-induced factor (Hypoxia Inducible Factor, HIF). HIF is therefore a key transcription factor, activated by hypoxia. The HIF1A, EPAS1 and HIF3A genes, which express the three HIF factors, HIF-1, HIF-2 and HIF-3 respectively. HIF factors by various mechanisms affect various target genes that promote cell proliferation, immortality and survival, angiogenesis, metabolic reprogramming of glucose and lipids, transition from epithelial to mesenchymal state and infiltration, and infiltration. The aim of the present study is to evaluate the expression of HIF-1α and HIF-2α, as well as their oxygen-dependent regulatory proteins PHD1, PHD2 and PHD3 and FIH in CP using immunohistochemistry. Comparison of their expression in cancerous tissue and in the adjacent microscopic non-cancerous tissue of the same radical prostatectomy preparation. The correlation of the degree of their expression with clinical pathological data of the patient and the disease. The future application in the study of biomarkers and pharmacotherapies for CP. The calibration of the total expression for each factor, we characterize the staining intensity with a score from 0-4 and the staining percentage from 1-4, we add them and thus we get a score per factor for cancerous and non-cancerous tissue. We then subtract the score of the adjacent microscopically normal tissue from the cancerous one and call the result the biological significance of each factor in a particular patient. There is a statistically significant difference with a positive sign (ie greater expression in cancerous tissue) between cancerous and non-cancerous tissue for HIF-2a and PHD2. This means overexpression of both factors in cancer tissue. There is a statistically significant correlation of overexpression of HIF-2a with Gleason score and ISUP grade. There is a correlation with higher Gleason score in the overexpression group. Only for HIF-2a is overexpression correlated with higher Gleason scores. In order to reliably assess the expression of the proteins under investigation by immunohistochemistry, their expression was determined in both cancer and adjacent microscopic normal tissue of each sample, to compare the true expression difference in each patient. This is an important element of the reliability of the study. The main conclusions of the study are:-HIF-2a is overexpressed in 52% of cancer tissue in patients with CKD. It plays a more important role in the creation, survival and development of the tumor.-HIF-2α overexpression is significantly correlated with the degree of malignancy of the disease, as expressed by the Gleason score and the ISUP grade of CP.-the study methodology is original. -The comparative control of the expression of the proteins under study in the cancerous area of the gland in relation to the adjacent non-cancerous one allowed the balancing of the genetic differences between different patients with CP and thus the more objective comparison.-HIF-1a appeared to be less pronounced in cancer than in non-cancerous tissue in contrast to previous publications -there were different correlations of proteins with each other. eg PHD1, PHD2 and PHD3 were related to each other in their expression.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Pavlakis, Dimitrios
  • Παυλάκης, Δημήτριος

Subjects

dc:subject × 14

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/48858

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Pavlakis, Dimitrios; Παυλάκης, Δημήτριος. Ανοσοϊστοχημική μελέτη έκφρασης πρωτεϊνών που σχετίζονται με την υποξία των όγκων στον καρκίνο του προστάτη: συσχέτιση με κλινικοεργαστηριακούς δείκτες. Aristotle University Of Thessaloniki (AUTH), 2021. http://hdl.handle.net/10442/hedi/48858